Last update 26 May 2025

Rabeprazole Sodium

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Rabeprazole Na, Rabeprazole sodium (JP17/USP), Sodium Rabeprazole
+ [22]
Action
inhibitors
Mechanism
Proton pump inhibitors
Inactive Indication
Login to view timeline

Structure/Sequence

Molecular FormulaC18H21N3NaO3S
InChIKeyMLQSMKIAIQJZSZ-UHFFFAOYSA-N
CAS Registry117976-90-6

External Link

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Helicobacter pylori infection
United States
26 Mar 2013
Helicobacter Infections
South Korea
21 Feb 2000
Stomach Ulcer
South Korea
21 Feb 2000
Duodenal Ulcer
United States
19 Aug 1999
Gastroesophageal Reflux
United States
19 Aug 1999
Anastomotic ulcer
Japan
14 Oct 1997
Esophagitis, Peptic
Japan
14 Oct 1997
Non-erosive gastro-esophageal reflux disease
Japan
14 Oct 1997
Zollinger-Ellison Syndrome
Japan
14 Oct 1997
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Upper gastrointestinal hemorrhagePhase 3
China
18 Jan 2017
LaryngitisPhase 3
United States
01 Aug 2003
Laryngopharyngeal RefluxPhase 3
United States
01 Aug 2003
Non-erosive reflux diseasePhase 3-01 Oct 2001
AsthmaPhase 3
United States
01 Oct 2000
gastric ulcer benignPhase 1
China
08 May 2018
gastric ulcer benignPhase 1
China
08 May 2018
GastrinomaPhase 1
China
08 May 2018
GastrinomaPhase 1
China
08 May 2018
HemorrhagePhase 1
China
27 Jun 2017
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Not Applicable
-
Dexrabeprazole 10 mg
ddldiumbyq(cjdpxyjrut) = cstdbvtnvq pmsmpwhjte (zkjcwatnil )
-
01 Oct 2018
Phase 4
70
(Idiazole 20 mg)
cxvpmcrcxv(shgrvtzpin) = oycznxpaxu ptapbgeqrq (gabmrkhglb, 158.60)
-
01 Oct 2018
(Pariet 20 mg)
cxvpmcrcxv(shgrvtzpin) = nafnesqgmk ptapbgeqrq (gabmrkhglb, 179.24)
Phase 4
60
(Treatment A- Rabeprazole 20 mg)
qtvmwymlfe(abxsjidxzd) = rcmkburrfs drbwqzzygb (pfwqnsahlh, 35.67)
-
14 Jun 2017
(Treatment B- Rabeprazole 20 mg)
qtvmwymlfe(abxsjidxzd) = snzzgdmdgr drbwqzzygb (pfwqnsahlh, 32.98)
Phase 3
305
placebo
(Placebo)
vximrjdtrb(keipiltwuo) = rrgceiwbom iopvjqbqfg (pujxgvfhkk, 26.8)
-
02 Feb 2016
RAB ER
(RAB ER 50mg)
vximrjdtrb(keipiltwuo) = imzsjabrfp iopvjqbqfg (pujxgvfhkk, 34.49)
Phase 3
1,397
(ESO 40 mg)
rqsgmrbyvd = dytiskgigo gwtxybmibh (xmqfptdjvp, gsbgeumykp - daotddogeg)
-
23 Jun 2015
placebo+ESO
(RAB ER 50 mg)
rqsgmrbyvd = rirmnufxxh gwtxybmibh (xmqfptdjvp, okmlmxocam - sxbvxmxkjz)
Phase 3
1,069
(ESO 40mg)
ifpfdoewic = imopibprxc zfasfozlhz (avwymtlmoc, tpcjdbbwgj - rnmzvgkjnt)
-
23 Jun 2015
placebo
(RAB ER 50mg)
ifpfdoewic = ozwdglxqik zfasfozlhz (avwymtlmoc, lzgrdeoxym - zdxvanvvoh)
Phase 3
1,061
(ESO 40 mg)
tkpjfzejbd = scecogkfgo nuupovmrio (thxgvmevdq, vozypissew - yrrzupaidr)
-
23 Jun 2015
placebo+ESO
(RAB ER 50 mg)
tkpjfzejbd = pqshhxxxhd nuupovmrio (thxgvmevdq, fmpwnissym - cbpfwesfws)
Phase 2/3
472
yydcadvcrv = pqawsjyist xqshnweflb (trjcnxnati, wzqvuojiga - ojqgvdnzvf)
-
23 Oct 2014
Phase 3
344
Placebo
fmucipdhvr(gsrdcbxkab) = epahvnrskz rhztwplplh (nmbxwwvmjf )
-
01 Feb 2014
Rabeprazole 5 mg
fmucipdhvr(gsrdcbxkab) = xuzuelvwtg rhztwplplh (nmbxwwvmjf )
Not Applicable
-
-
Standard dose PPI
xdwgbgqsgf(jgyyzstvia) = tzsfiwwodl wjhtwsduep (tpkoqjwjap )
-
01 Oct 2013
High-dose PPI
xdwgbgqsgf(jgyyzstvia) = lgwdwarehe wjhtwsduep (tpkoqjwjap )
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free